Trevi Therapeutics Inc.

TRVI | NASDAQ

Price Alert Chart Builder DCF Calculator

$15.24

+$0.35 (+2.35%)

At close: Sep 22, 2026, 4:00 PM ET

$15.24

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.11B

Enterprise Value $1.8B

Beta 1.05

Average Volume 1.91M

Shares Outstanding (Diluted) 156.6M

Shares Change YoY 20.14%

Institutional Ownership 92.68%

Exchange NASDAQ

ISIN US89532M1018

Price Performance

Price Change 1M -16.3%

Price Change 3M -14.3%

Price Change 6M 30.2%

Price Change YTD 25.2%

Price Change 1Y 74.2%

Price Change 3Y 602.4%

Price Change 5Y 934.0%

1M CAGR (ann.) -19.6%

1Y CAGR (ann.) 74.4%

5Y CAGR (ann.) 58.3%

All-Time CAGR 9.0%

Valuation

PE Ratio -43.79

Forward PE N/A

PEG Ratio -2.31

Forward PEG -1.59

PS Ratio N/A

Forward PS 609.80

PB Ratio 6.58

P/FCF Ratio -53.67

P/Adj. FCF Ratio -44.56

P/OCF Ratio -43.79

EV/Sales N/A

EV/EBIT -35.09

EV/EBITDA -35.16

EV/FCF -45.59

Earnings Yield -2.3%

FCF Yield -1.9%

Adj. FCF Yield -2.2%

Financial Health

Net Cash $318.27M

Total Debt $605K

Cash & Short-Term Investments $318.87M

Total Assets $330.52M

Current Ratio 37.28

Quick Ratio 37.28

Debt / Equity Ratio 0.00

Debt / EBITDA -0.01

Debt / FCF -0.02

OCF / Debt -86.99

Interest Coverage 0.00

Altman Z-Score 139.86

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -20.4%

Returns

Return on Assets -15.5%

Return on Equity -23.6%

Return on Invested Capital -18.5%

Return on Capital Employed -18.5%

Return on Tangible Assets -15.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 6.5%

EPS CAGR 5Y 27.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y -8.5%

FCF CAGR 5Y -9.9%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 18

EPS Growth Next 3Y -36.3%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.13

EPS Growth Est (next Q) 62.5%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $29.67

Price Target Upside 99.3%

Cash Flow

Operating Cash Flow $-52.63M

Free Cash Flow $-39.39M

Adj. Free Cash Flow $-47.45M

FCF Per Share -$0.25

OCF Per Share -$0.34

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-34K

Operating Income $-59.56M

EBITDA $-51.07M

Net Income $-51.11M

EPS (Diluted) -$0.34

Revenue / Employee N/A

Profit / Employee $-1.5M

Employees 34